Eisai unveiled its 2008 Senior Health Digest at the Academy of Managed Care Pharmacy's 20th Annual Meeting & Showcase, in April.

I recently attended the PMRG conference in Phoenix, and came away with several realizations.

Form true partnerships with your clients, keep them happy and make your recommendations short and sweet—that's the message from pharma companies to their marketing research suppliers and consultants, according to a new study by marketRx, a Cognizant Company.

I'll bet that if you hear one more person in our industry talk about the pressure being applied on marketing researchers to do more with less, you will scream.

The research arm of investment banking firm Goldman Sachs will look to promote Epocrates' marketing research services.

While data mining laws are mired in court, alternatives are helping physicians control rep encounters and help states manage costs.

As this is being written, word came across that IMS, that venerable organization of pharma marketing research, was about to lay off 10% of its work force.

A document recently crossed my desk that was so seminal I needed to share it with my colleagues through this column.

A Maine law that would have limited access by medical data companies to doctors' prescription information was reversed on constitutional grounds.

IMS Health said it intends to lay off 10% of its workforce, or as many as 760 employees worldwide.